stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Shares outstanding
Neogen Corporation's shares outstanding at the end of fiscal 2026 was $217.5M, unchanged from fiscal 2025. At the end of the quarter to 31 August 2026 it was $218.1M. Over the past ten years it has ranged from $99.8M (fiscal 2015) to $217.5M (fiscal 2026) — the current reading is the highest in ten years. Neogen Corporation ranks 15th of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $217.5M | 0.28% |
| FY2025 | $216.9M | 0.18% |
| FY2024 | $216.5M | 14.62% |
| FY2023 | $188.9M | 74.86% |
| FY2022 | $108.0M | 0.84% |
| FY2021 | $107.1M | 1.32% |
| FY2020 | $105.7M | 0.83% |
| FY2019 | $104.9M | 0.53% |
| FY2018 | $104.3M | 1.92% |
| FY2017 | $102.3M | 1.32% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Aug 2026 | $218.1M | 0.28% |
| May 2026 | $217.5M | (0.09%) |
| Feb 2026 | $217.7M | 0.13% |
| Nov 2025 | $217.4M | 0.05% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BFLY Butterfly Network, Inc. compare | $266.5M |
| NEOG Neogen Corporation | $218.1M |
| ALMR Alamar Biosciences, Inc. compare | $69.1M |
| AXGN AxoGen, Inc. compare | $61.5M |
| TMDX TransMedics Group, Inc. compare | $40.8M |
| ITGR Integer Holdings Corporation compare | $34.6M |
| ESTA Establishment Labs Holdings Inc. compare | $30.1M |
| INSP Inspire Medical Systems, Inc. compare | $28.9M |
| UFPT UFP Technologies, Inc. compare | $7.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement